Department of Cardiovascular Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Faculty of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
Cardiovasc Ultrasound. 2022 Aug 12;20(1):22. doi: 10.1186/s12947-022-00291-4.
Although cardiac magnetic resonance (CMR) is the most reliable tool for assessment of CIO in patients with thalassemia, it is not always readily available. Recent studies have explored the potential of GLS as an alternative for diagnosis of CIO. We aimed to investigate the efficacy of global longitudinal strain (GLS) for detection of cardiac iron level (CIO).
We searched SCOPUS, MEDLINE, and Embase to identify the studies which used GLS for assessment of CIO. We searched for individual participant data (IPD) in eligible studies to perform ROC curve analysis. CMR with a T2* cut-off value of 20 ms was considered as the gold standard. A meta-analysis was performed and the risk of bias was assessed using the JBI Checklist.
A total of 14 studies with 789 thalassemia patients (310 and 430 with and without CIO respectively and 49 with undetermined condition) were considered eligible for meta-analysis. IPDs of 405 participants were available. GLS was significantly lower in patients with CIO (-17.5 ± 2.7%) compared to those without CIO (-19.9 ± 2.3%; WMD = 1.6%, 95% CI = [0.76-2.4], p = 0.001, I = 77.1%) and to normal population (-20.61 ± 2.26%; WMD = 2.2%, 95% CI = [0.91-3.5], p = 0.001, I = 83.9%). A GLS < -19.5% could predict CIO with 92.8% sensitivity and 34.63% specificity (AUC = 0.659, 95% CI = [0.6-0.72], p-value < 0.0001). A GLS value < -6% has 100% positive predictive and ≥ -24.5% has 100% negative predictive values for detection of CIO.
According to our study, GLS is a strong predictor of CIO and when CMR is not available, it may be a useful screening method for identification of CIO in thalassemia patients.
尽管心脏磁共振(CMR)是评估地中海贫血患者铁超负荷(CIO)最可靠的工具,但它并非总是随时可用。最近的研究已经探索了整体纵向应变(GLS)作为诊断 CIO 的替代方法。我们旨在研究整体纵向应变(GLS)检测心脏铁水平(CIO)的效果。
我们在 SCOPUS、MEDLINE 和 Embase 中搜索了使用 GLS 评估 CIO 的研究。我们在符合条件的研究中搜索了个体参与者数据(IPD),以进行 ROC 曲线分析。CMR 的 T2*截断值为 20ms 被认为是金标准。我们进行了荟萃分析,并使用 JBI 清单评估了偏倚风险。
共有 14 项研究,涉及 789 名地中海贫血患者(分别有 310 名和 430 名患者患有或不患有 CIO,以及 49 名患者不确定情况),被认为符合荟萃分析的条件。共有 405 名参与者的 IPD 可用。患有 CIO 的患者的 GLS 明显低于不患有 CIO 的患者(-17.5±2.7% 比-19.9±2.3%;WMD=1.6%,95%CI=[0.76-2.4],p=0.001,I=77.1%)和正常人群(-20.61±2.26%;WMD=2.2%,95%CI=[0.91-3.5],p=0.001,I=83.9%)。GLS<-19.5%可以预测 CIO,其敏感性为 92.8%,特异性为 34.63%(AUC=0.659,95%CI=[0.6-0.72],p 值<0.0001)。GLS 值<-6%对检测 CIO 有 100%的阳性预测值,≥-24.5%有 100%的阴性预测值。
根据我们的研究,GLS 是 CIO 的有力预测指标,当 CMR 不可用时,它可能是一种有用的筛选方法,用于识别地中海贫血患者的 CIO。